| C09DA07 |
Telmisartan, Hydrochlorothiazide |
Telsol Plus |
Tablet |
80 mg/25 mg |
mg |
28 |
Инбиотех ООД, България |
1 |
tabl |
- |
12.14 |
0.298 |
8.34 |
50% |
4.17 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-8371/26.02.2016 |
02.06.2019 |
|
|
Активен |
4204 |
| C09DA07 |
Telmisartan, Hydrochlorothiazide |
Telsol Plus |
Tablet |
80 mg/12,5 mg |
|
28 |
Инбиотех ООД, България |
1 |
tabl |
- |
9.44 |
0.298 |
8.34 |
50% |
4.17 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11961/10.03.2017; НСР-16462/17.08.2018 |
02.06.2019 |
|
|
Активен |
15625 |
| C09DA07 |
Telmisartan, Hydrochlorothiazide |
Tezeo HCT |
Tablet |
80 mg/ 12.5 mg |
mg |
30 |
Zentiva k.s., Чешка република |
1 |
tabl |
- |
9.07 |
0.298 |
8.94 |
50% |
4.47 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-4274/05.08.2014; НСР-7304/29.10.2015 |
02.06.2019 |
|
|
Активен |
3073 |
| C09DA07 |
Telmisartan, Hydrochlorothiazide |
Tolucombi |
Tablet |
80 mg/12,5 mg |
mg |
30 |
KRKA, d.d., Словения |
1 |
tabl |
- |
9.83 |
0.298 |
8.94 |
50% |
4.47 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
HCР-629/26.07.2013; НСР-7065/09.09.2015; НСР-14473/17.11.2017 |
02.06.2019 |
|
|
Активен |
1964 |
| C09DA07 |
Telmisartan, Hydrochlorothiazide |
Tolucombi |
Tablet |
80 mg/25 mg |
mg |
30 |
KRKA, d.d., Словения |
1 |
tabl |
- |
9.83 |
0.298 |
8.94 |
50% |
4.47 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
HCР-629/26.07.2013; НСР-7065/09.09.2015; НСР-14474/17.11.2017 |
02.06.2019 |
|
|
Активен |
1965 |
| C09DA08 |
Olmesartan medoxomil/ Hydrochlorothiazide |
C09DA08 Olmesartan medoxomil/ Hydrochlorothiazide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Coolsart |
Film coated tablet |
40 mg/25 mg |
|
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
108 |
0.46167 |
13.85 |
50% |
6.92 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11681/10.02.2017 |
02.09.2019 |
|
|
Активен |
15600 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Coolsart |
Film coated tablet |
40 mg/12,5 mg |
|
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
52.27 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-10654/21.10.2016; НСР-17719/10.01.2019 |
02.02.2019 |
|
|
Активен |
15454 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Coolsart |
Film coated tablet |
20 mg/12,5 mg |
|
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
86.4 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-10654/21.10.2016 |
02.09.2018 |
|
|
Активен |
15453 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Coolsart |
Film coated tablet |
20 mg/25 mg |
|
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
86.4 |
0.41783 |
12.53 |
50% |
6.26 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11681/10.02.2017 |
02.09.2018 |
|
|
Активен |
15599 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Neosara-Co |
Film coated tablet |
40 mg/12.5 mg |
|
30 |
МС Фарма АД, България |
1 |
tabl |
- |
38.51 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-17982/21.02.2019 |
02.04.2019 |
|
|
Активен |
16442 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Neosara-Co |
Film coated tablet |
20 mg/12.5 mg |
|
30 |
МС Фарма АД, България |
1 |
tabl |
- |
27.22 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-17982/21.02.2019 |
02.04.2019 |
|
|
Активен |
16443 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesartan/HCTZ Mylan |
Film coated tablet |
40 mg/12.5 mg |
|
30 |
Mylan Ireland Limited, Ирландия |
1 |
tabl |
- |
13.85 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-13326/28.07.2017; НСР-16948/04.10.2018; НСР-18008/21.02.2019 |
02.04.2019 |
|
|
Активен |
15806 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesartan/HCTZ Mylan |
Film coated tablet |
20 mg/12.5 mg |
|
30 |
Mylan Ireland Limited, Ирландия |
1 |
tabl |
- |
13.85 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-13326/28.07.2017; НСР-16950/04.10.2018; НСР-18007/21.02.2019 |
02.04.2019 |
|
|
Активен |
15805 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesartan/ Hydrochlorothiazide Aurobindo |
Film coated tablet |
40 mg/12,5 mg |
|
28 |
Aurobindo Pharma (Malta) Limited, Малта |
1 |
tabl |
- |
12.9 |
0.46071 |
12.9 |
50% |
6.45 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11679/10.02.2017; НСР-15656/17.05.2018 |
02.06.2018 |
|
|
Активен |
15597 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesta Plus |
Film coated tablet |
20 mg/25 mg |
mg |
30 |
Teva B.V., Нидерландия |
1 |
tabl |
- |
13.85 |
0.41783 |
12.53 |
50% |
6.26 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-19511/14.08.2019 |
02.09.2019 |
|
|
Активен |
16659 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesta Plus |
Film coated tablet |
40 mg/25 mg |
mg |
30 |
Teva B.V., Нидерландия |
1 |
tabl |
- |
13.85 |
0.46167 |
13.85 |
50% |
6.92 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-19511/14.08.2019 |
02.09.2019 |
|
|
Активен |
16660 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesta Plus |
Film coated tablet |
40 mg/12.5 mg |
|
30 |
Teva B.V., Нидерландия |
1 |
tabl |
- |
13.85 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-2364/21.02.2012.; HCP-8621/31.03.2016.; НСР-12872/02.06.2017; НСР-16482/17.08.2018; НСР-19214/12.07.2019 |
02.08.2019 |
|
|
Активен |
1646 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmesta Plus |
Film coated tablet |
20 mg/12.5 mg |
|
30 |
Teva B.V., Нидерландия |
1 |
tabl |
- |
13.85 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-2363/21.02.2012 .; HCP-8621/31.03.2016.; НСР-12871/02.06.2017; НСР-16481/17.08.2018; НСР-19213/12.07.2019 |
02.08.2019 |
|
|
Активен |
1645 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmezide plus |
Film coated tablet |
20 mg/12,5 mg |
|
30 |
Stada Arzneimittel AG, Германия |
1 |
tabl |
- |
20.36 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11393/13.01.2017; НСР-17260/14.11.2018 |
02.12.2018 |
|
|
Активен |
15565 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Olmezide plus |
Film coated tablet |
40 mg/12,5 mg |
|
30 |
Stada Arzneimittel AG, Германия |
1 |
tabl |
- |
27.01 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11393/13.01.2017; НСР-17259/14.11.2018 |
02.12.2018 |
|
|
Активен |
15566 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Tansidor H |
Film coated tablet |
20 mg/12,5 mg |
|
30 |
Sandoz d.d., Словения |
1 |
tabl |
- |
17.81 |
0.33408 |
10.02 |
50% |
5.01 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11049/01.12.2016; НСР-15110/26.02.2018 предварително изпълнение; НСР-18563/25.04.2019; НСР-20963/05.03.2020; НСР-21073/30.03.2020 Предварително изпълнение** |
02.04.2020 |
|
|
Заличен |
15510 |
| C09DA08 |
Olmesartan medoxomil, Hydrochlorothiazide |
Tansidor H |
Film coated tablet |
40 mg/12,5 mg |
|
30 |
Sandoz d.d., Словения |
1 |
tabl |
- |
19.52 |
0.46071 |
13.82 |
50% |
6.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11049/01.12.2016; НСР-15109/26.02.2018 предварително изпълнение; НСР-18566/25.04.2019; НСР-20963/05.03.2020; НСР-21073/30.03.2020 Предварително изпълнение |
02.04.2020 |
|
|
Заличен |
15512 |
| C09DB01 |
Amlodipine/ Valsartan |
C09DB01 Amlodipine/ Valsartan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09DB01 |
Amlodipine, Valsartan |
Amlodipine/Valsartan Mylan |
Film coated tablet |
10 mg/160 mg |
|
30 |
Mylan S.A.S., Франция |
1 |
tabl |
- |
18.42 |
0.30466 |
9.14 |
50% |
4.57 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-13197/17.07.2017; НСР-16951/04.10.2018 |
02.11.2018 |
|
|
Активен |
15794 |